BACKGROUND: Historically, studies of adherence to airway clearance therapy in cystic fibrosis (CF) have relied on self-reporting. We compared self-reported airway clearance therapy adherence to actual usage data from home high-frequency chest wall compressions (HFCWC) vests and identified factors associated with overestimation of adherence in self-reports. METHODS: Pediatric patients who perform airway clearance therapy with a HFCWC vest were eligible to participate. Objective adherence data were obtained from the HFCWC device, which records cumulative utilization time. Two readings at least 5 weeks apart were collected. Objective adherence was recorded as a ratio of mean-to-prescribed daily use (%). Self-reported adherence data were collected with a caregiver survey at enrollment. Adherence rates were categorized as low (< 35% of prescribed), moderate (36-79% of prescribed), and high (≥ 80% of prescribed). An overestimation was present when self-reported adherence was at least one category higher than objective adherence. RESULTS: In the final sample (N = 110), mean adherence by usage data was 61%. Only 35% of subjects (n = 38) were highly adherent, and 28% (n = 31) were low adherent. In contrast, 65% of subjects (n = 72) reported high adherence and only 8% (n = 9) reported low adherence (P < .001). Nearly half of self-reports (46%) overestimated adherence. In a multiple regression analysis, overestimation was associated with multiple airway clearance therapy locations (odds ratio 7.13, 95% CI 1.16-43.72, P = .034) and prescribed daily use ≥ 60 min (odds ratio 3.85, 95% CI 1.08-13.76, P < .038). Among subjects with prescribed daily airway clearance therapy ≥ 60 min, the odds of overestimating adherence increased 3-fold (odds ratio 3.04, 95% CI 1.17-7.87, P = .02) in a lower-income (< $50,000/y) environment. CONCLUSIONS: Self-reports overestimated actual adherence to airway clearance therapy, and the overestimation increased with treatment occurring in multiple households and prescribed therapy duration. Among participants with prescribed airway clearance therapy ≥ 60 min, overestimation increased with lower income. Objective measures of adherence are needed, particularly for lower-income children and those receiving treatments in multiple locations.

Children's Hospital of Alabama Birmingham Alabama

Department of Sociology University of Alabama at Birmingham and Research Center for Toxic Compounds in the Environment Masaryk University Czech Republic

Departments of Medicine and Cell Developmental and Integrative Biology University of Alabama at Birmingham

Division of Pediatric Pulmonary and Sleep Medicine as well as the Gregory Fleming James Cystic Fibrosis Research Center University of Alabama at Birmingham Alabama

Zobrazit více v PubMed

Haynes RB, Taylor DW, Sackett DL. Compliance in health care. Baltimore MD: Johns Hopkins University Press; 1979.

Morse JM, Mitcham C, Hupcey JE, Tason MC. Criteria for concept evaluation. J Adv Nurs 1996;24(2):385–390. PubMed

Hommel KA, Greenley RN, Maddux MH, Gray WN, Mackner LM. Self-management in pediatric inflammatory bowel disease: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2013;57(2):250–257. PubMed PMC

Collaco JM, Kole AJ, Riekert KA, Eakin MN, Okelo SO, McGrath-Morrow SA. Respiratory medication adherence in chronic lung disease of prematurity. Pediatr Pulmonol 2012;47(3):283–291. PubMed PMC

Modi AC, Lim CS, Yu N, Geller D, Wagner MH, Quittner AL. A multi-method assessment of treatment adherence for children with cystic fibrosis. J Cyst Fibros 2006;5(3):177–185. PubMed

Hommel KA, Davis CM, Baldassano RN. Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2009;15(4):589–593. PubMed PMC

Cook CL, Wade WE, Martin BC, Perri M., 3rd Concordance among three self-reported measures of medication adherence and pharmacy refill records. J Am Pharm Assoc (2003) 2005;45(2):151–159. PubMed

Eakin MN, Bilderback A, Boyle MP, Mogayzel PJ, Riekert KA. Longitudinal association between medication adherence and lung health in people with cystic fibrosis. J Cyst Fibros 2011;10(4):258–264. PubMed PMC

DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002;40(9):794–811. PubMed

Cystic Fibrosis Foundation Patient Registry: 2013 Annual Data Report to Center Directors. Bethesda, Maryland:Cystic Fibrosis Foundation;2014. https://www.cff.org/2013_CFF_Annual_Data_Report_to_the_Center_Directors.pdf.

Llorente RPA, Garcia CB, Martin JJD. Treatment compliance in children and adults with Cystic Fibrosis. J Cyst Fibros 2008;7(5):359–367. PubMed

Sontag MK, Quittner AL, Modi AC, Koenig JM, Giles D, Oermann CM, et al. Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis. Pediatr Pulmonol 2010;45(3):291–300. PubMed PMC

Quittner AL, Drotar D, Ievers-Landis C. Adherence to medical treatments in adolescents with cystic fibrosis: the development and evaluation of family based interventions. In: Drotar D, editors. Promoting adherence to medical treatment in childhood chronic illness: concepts, methods, and interventions. Hillsdale, NJ: Erlbaum Associates; 2000.

Daniels T, Goodacre L, Sutton C, Pollard K, Conway S, Peckham D. Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers. Chest 2011;140(2):425–432. PubMed

Mikesell CL, Kempainen RR, Laguna TA, Menk JS, Wey AR, Gaillard PR, et al. Objective measurement of adherence to out-patient airway clearance therapy by high-frequency chest wall compression in cystic fibrosis. Respir Care 2017;62(7):920–927. PubMed PMC

Oates GR, Stepanikova I, Gamble S, Gutierrez HH, Harris WT. Adherence to airway clearance therapy in pediatric cystic fibrosis: socioeconomic factors and respiratory outcomes. Pediatr Pulmonol 2015;50(12):1244–1252. PubMed PMC

Quittner AL, Modi AC, Lemanek KL, Ievers-Landis CE, Rapoff MA. Evidence-based assessment of adherence to medical treatments in pediatric psychology. J Pediatr Psychol 2008;33(9):916–936. PubMed PMC

Modi AC, Cassedy AE, Quittner AL, Accurso F, Sontag M, Koenig JM, et al. Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis. J Pediatr Psychol 2010;35(9):1028–1037. PubMed

Wang XB, Dockery DW, Wypij D, Fay ME, Ferris BG. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993;15(2):75–88. PubMed

Jerant A, DiMatteo R, Arnsten J, Moore-Hill M, Franks P. Self-report adherence measures in chronic illness: retest reliability and predictive validity. Med Care 2008;46(11):1134–1139. PubMed

Cecere LM, Slatore CG, Uman JE, Evans LE, Udris EM, Bryson CL, et al. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD 2012;9(3):251–258. PubMed

Burge S, White D, Bajorek E, Bazaldua O, Trevino J, Albright T, et al. Correlates of medication knowledge and adherence: findings from the residency research network of South Texas. Fam Med 2005;37(10):712–718. PubMed

Ricker JH, Delamater AM, Hsu J. Correlates of regimen adherence in cystic fibrosis. J Clin Psychol Med Settings 1998;5(2):159–172.

Modi AC, Quittner AL. Barriers to treatment adherence for children with cystic fibrosis and asthma: what gets in the way? J Pediatr Psychol 2006;31(8):846–858. PubMed

The future of cystic fibrosis care: a global perspective